End of induction [ 18 F]FDG PET is prognostic for progression-free survival and overall survival in follicular lymphoma patients enrolled in the FOLL12 trial.
Luca GuerraStephane ChauvieFederico FallancaFabrizio BergesioLuigi MarcheselliRexhep DurmoSimona PeanoAntonella FranceschettoLavinia MonacoEmiliano BarbieriMarco LadettoGerardo MusuracaPatrizia TosiBenedetta BianchiSilvia Anna Maria BolisVincenzo PavoneAnnalisa ChiarenzaAnnalisa ArcariCatello CalifanoAlessia BariMassimo MassaiaAnnarita ConconiPellegrino MustoDonato ManninaGiovanni RotiSara GalimbertiGuido GiniFlavio FalcinelliUmberto VitoloSara Veronica UsaiPiero Maria StefaniAdalberto IbaticiAnna Marina LiberatiElsa PenneseTommasina PerroneAnnibale VersariStefano Luminarinull nullPublished in: European journal of nuclear medicine and molecular imaging (2024)
This study shows that DS is a reliable prognostic tool to evaluate EOI PET in follicular lymphoma patients, with prognostic value maintained both in the standard and experimental arms, making metabolic imaging a robust tool to assess response in FL. Moreover, although preliminary, this study provides further information on DS3 patients, who are considered as CMR but show a less favourable PFS than DS1-2 patients.